Literature DB >> 12650604

MKK4 and metastasis suppression: a marriage of signal transduction and metastasis research.

Victoria L Robinson1, Jonathan A Hickson, Donald J Vander Griend, Zita Dubauskas, Carrie W Rinker-Schaeffer.   

Abstract

MAP kinase kinase 4 (MKK4) is a member of the stress-activated protein kinase (SAPK) signaling cascade and is involved in the regulation of many cellular processes. We have recently demonstrated a functional role for MKK4 in the suppression of metastases. In this review, we discuss the established cellular and biochemical functions of MKK4, as well as a new function for MKK4 as a metastasis suppressor gene. Because of the importance of signaling studies to this translational work, a detailed example of the strategy and tools that can be employed to define the biochemical mechanism of MKK4-mediated metastasis suppression is presented. Finally, the potential therapeutic utility of these findings is discussed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12650604     DOI: 10.1023/a:1022586318678

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  22 in total

Review 1.  Defining the biologic role of genes that regulate prostate cancer metastasis.

Authors:  C W Rinker-Schaeffer; D R Welch; M Sokoloff
Journal:  Curr Opin Urol       Date:  2000-09       Impact factor: 2.309

Review 2.  Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation.

Authors:  J M Kyriakis; J Avruch
Journal:  Physiol Rev       Date:  2001-04       Impact factor: 37.312

3.  Mutation rate of MAP2K4/MKK4 in breast carcinoma.

Authors:  Gloria H Su; Jason J Song; Elizabeth A Repasky; Mieke Schutte; Scott E Kern
Journal:  Hum Mutat       Date:  2002-01       Impact factor: 4.878

4.  Activation of p38 mitogen-activated protein kinase by lipopolysaccharide in human neutrophils requires nitric oxide-dependent cGMP accumulation.

Authors:  D D Browning; N D Windes; R D Ye
Journal:  J Biol Chem       Date:  1999-01-01       Impact factor: 5.157

Review 5.  Signal transduction by the c-Jun N-terminal kinase (JNK)--from inflammation to development.

Authors:  Y T Ip; R J Davis
Journal:  Curr Opin Cell Biol       Date:  1998-04       Impact factor: 8.382

6.  Mitogen-activated protein kinase kinase 4 metastasis suppressor gene expression is inversely related to histological pattern in advancing human prostatic cancers.

Authors:  H L Kim; D J Vander Griend; X Yang; D A Benson; Z Dubauskas; B A Yoshida; M A Chekmareva; Y Ichikawa; M H Sokoloff; P Zhan; T Karrison; A Lin; W M Stadler; T Ichikawa; M A Rubin; C W Rinker-Schaeffer
Journal:  Cancer Res       Date:  2001-04-01       Impact factor: 12.701

Review 7.  Mitogen-activated protein kinase kinase 4 (MKK4).

Authors:  A Cuenda
Journal:  Int J Biochem Cell Biol       Date:  2000-06       Impact factor: 5.085

8.  The kinetic mechanism of the dual phosphorylation of the ATF2 transcription factor by p38 mitogen-activated protein (MAP) kinase alpha. Implications for signal/response profiles of MAP kinase pathways.

Authors:  W F Waas; H H Lo; K N Dalby
Journal:  J Biol Chem       Date:  2000-11-07       Impact factor: 5.157

Review 9.  Metastasis suppression: the evolving role of metastasis suppressor genes for regulating cancer cell growth at the secondary site.

Authors:  Eric C Kauffman; Victoria L Robinson; Walter M Stadler; Mitchell H Sokoloff; Carrie W Rinker-Schaeffer
Journal:  J Urol       Date:  2003-03       Impact factor: 7.450

10.  Chromosome 17-mediated dormancy of AT6.1 prostate cancer micrometastases.

Authors:  M A Chekmareva; M M Kadkhodaian; C M Hollowell; H Kim; B A Yoshida; H H Luu; W M Stadler; C W Rinker-Schaeffer
Journal:  Cancer Res       Date:  1998-11-01       Impact factor: 12.701

View more
  11 in total

Review 1.  Translational approaches using metastasis suppressor genes.

Authors:  Diane Palmieri; Christine E Horak; Jong-Heun Lee; Douglas O Halverson; Patricia S Steeg
Journal:  J Bioenerg Biomembr       Date:  2006-08       Impact factor: 2.945

2.  Regulation of the metastasis suppressor gene MKK4 in ovarian cancer.

Authors:  Monique A Spillman; Judith Lacy; Susan K Murphy; Regina S Whitaker; Lisa Grace; Vanessa Teaberry; Jeffrey R Marks; Andrew Berchuck
Journal:  Gynecol Oncol       Date:  2007-02-05       Impact factor: 5.482

3.  Reduced metastasis-suppressor gene mRNA-expression in breast cancer brain metastases.

Authors:  Andreas M Stark; Kerrin Tongers; Nicolai Maass; H Maximilian Mehdorn; Janka Held-Feindt
Journal:  J Cancer Res Clin Oncol       Date:  2004-12-08       Impact factor: 4.553

Review 4.  Gene dysregulations driven by somatic copy number aberrations-biological and clinical implications in colon tumors: a paper from the 2009 William Beaumont Hospital Symposium on Molecular Pathology.

Authors:  Manny D Bacolod; Francis Barany
Journal:  J Mol Diagn       Date:  2010-08-13       Impact factor: 5.568

5.  Targeting the p38 MAPK pathway inhibits irinotecan resistance in colon adenocarcinoma.

Authors:  Salomé Paillas; Florence Boissière; Fréderic Bibeau; Amélie Denouel; Caroline Mollevi; Annick Causse; Vincent Denis; Nadia Vezzio-Vié; Laetitia Marzi; Cédric Cortijo; Imade Ait-Arsa; Nadav Askari; Philippe Pourquier; Pierre Martineau; Maguy Del Rio; Céline Gongora
Journal:  Cancer Res       Date:  2010-12-15       Impact factor: 12.701

Review 6.  Crystallographic mining of ASK1 regulators to unravel the intricate PPI interfaces for the discovery of small molecule.

Authors:  Ashish Kumar Agrahari; Madhu Dikshit; Shailendra Asthana
Journal:  Comput Struct Biotechnol J       Date:  2022-07-11       Impact factor: 6.155

7.  Mitogen-activated protein kinase kinase 4/c-Jun NH2-terminal kinase kinase 1 protein expression is subject to translational regulation in prostate cancer cell lines.

Authors:  Victoria L Robinson; Ore Shalhav; Kristen Otto; Tomoko Kawai; Myriam Gorospe; Carrie W Rinker-Schaeffer
Journal:  Mol Cancer Res       Date:  2008-03       Impact factor: 5.852

Review 8.  Metastasis suppressors and their roles in breast carcinoma.

Authors:  Kedar S Vaidya; Danny R Welch
Journal:  J Mammary Gland Biol Neoplasia       Date:  2007-09       Impact factor: 2.673

9.  P38 MAPK expression and activation predicts failure of response to CHOP in patients with Diffuse Large B-Cell Lymphoma.

Authors:  Gabriel G Vega; Alejandro Avilés-Salas; J Ramón Chalapud; Melisa Martinez-Paniagua; Rosana Pelayo; Héctor Mayani; Rogelio Hernandez-Pando; Otoniel Martinez-Maza; Sara Huerta-Yepez; Benjamin Bonavida; Mario I Vega
Journal:  BMC Cancer       Date:  2015-10-16       Impact factor: 4.430

10.  Downregulation of CD147 expression alters cytoskeleton architecture and inhibits gelatinase production and SAPK pathway in human hepatocellular carcinoma cells.

Authors:  Ai-Rong Qian; Wei Zhang; Jian-Ping Cao; Peng-Fei Yang; Xiang Gao; Zhe Wang; Hui-Yun Xu; Yuan-Yuan Weng; Peng Shang
Journal:  J Exp Clin Cancer Res       Date:  2008-10-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.